Biggest changeThe following table summarizes revenues by our markets for the years ended September 30, 2022 and 2021, respectively (in thousands): 23 2022 2021 Revenue Percent of total revenue Revenue Percent of total revenue Human Services and Solutions $ 165,970 42.0 % $ 37,260 15.1 % Defense and Veteran Health Solutions 159,719 40.4 % 141,435 57.0 % Public Health and Life Sciences 69,484 17.6 % 67,399 27.9 % Total revenue $ 395,173 100.0 % $ 246,094 100.0 % Forward Looking Business Trends: Our mission is to expand our position as a trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services to active duty personnel, veterans, and civilian populations and communities.
Biggest changeThe following table summarizes the revenues by customer for the years ended September 30, 2023 and 2022, respectively (in thousands): 2023 2022 Revenue Percent of total revenue Revenue Percent of total revenue Department of Health and Human Services $ 161,311 42.9 % $ 102,201 25.9 % Department of Veterans Affairs 138,862 37.0 % 126,106 31.9 % Department of Defense 70,325 18.7 % 33,612 8.5 % Department of Homeland Security 919 0.2 % 126,576 32.0 % Customers with less than 10% share of total revenue 4,455 1.2 % 6,678 1.7 % Revenue $ 375,872 100.0 % $ 395,173 100.0 % The following table summarizes revenues by our markets for the years ended September 30, 2023 and 2022, respectively (in thousands): 2023 2022 Revenue Percent of total revenue Revenue Percent of total revenue Defense and Veteran Health Solutions $ 209,187 55.7 % $ 159,719 40.4 % Human Services and Solutions 110,068 29.3 % 165,970 42.0 % Public Health and Life Sciences 56,617 15.0 % 69,484 17.6 % Revenue $ 375,872 100.0 % $ 395,173 100.0 % 24 Forward Looking Business Trends: Our mission is to expand our position as a trusted provider of technology-enabled healthcare and public health services, medical logistics, and readiness enhancement services to active duty personnel, veterans, and civilian populations and communities.
This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax asset will not be realized. The Company has fully utilized its net operating loss carryforwards. Stock-based Equity Compensation The Company uses the fair value-based method for stock-based equity compensation.
This guidance also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some or all of the deferred tax assets will not be realized. The Company has fully utilized its net operating loss carryforwards. Stock-based Equity Compensation The Company uses the fair value-based method for stock-based equity compensation.
For the year ended September 30, 2022 net income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $125.8 million the following amounts associated with such task orders: contract costs of $112.1 million, general & administrative costs of $1.2 million, and provision for income taxes of $3.2 million.
For the fiscal year ended September 30, 2022, net income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $125.8 million the following amounts associated with such task orders: contract costs of $112.1 million, general & administrative costs of $1.2 million, and provision for income taxes of $3.2 million.
When control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. For services contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress.
When control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. For service contracts, we satisfy our performance obligations as services are rendered. We use cost-based input and time-based output methods to measure progress.
Refer to Note 4 of the accompanying notes to our consolidated financial statements contained elsewhere in this Annual Report on Form 10-K for discussion relative to the Company's revenue recognition in accordance with ASC-606. Long-lived Assets Our long-lived assets include equipment and improvements, right-of-use assets, intangible assets, and goodwill.
Refer to Note 5 of the accompanying notes to our consolidated financial statements contained elsewhere in this Annual Report on Form 10-K for discussion relative to the Company's revenue recognition in accordance with ASC-606. Long-lived Assets Our long-lived assets include equipment and improvements, right-of-use assets, intangible assets, and goodwill.
Similarly, for the year ended September 30, 2022 operating income for the FEMA task orders is derived by subtracting from the revenue attributable to the tasks orders of $125.8 million the following amounts associated with such task orders: contract costs $112.1 million and general & administrative costs of $1.2 million.
Operating income for the FEMA task orders for the fiscal year ended September 30, 2022, is derived by subtracting from the revenue attributable to the tasks orders of $125.8 million the following amounts associated with such task orders: contract costs $112.1 million and general & administrative costs of $1.2 million.
While Congress has not completed the final appropriation bills for the government’s 2023 fiscal year, the Company continues to believe that its key programs benefit from bipartisan support and does not expect a material impact on its current business base from budget negotiations.
While Congress has not completed the final appropriation bills for the government’s 2024 fiscal year, the Company continues to believe that its key programs benefit from bipartisan support and does not expect a material impact on its current business base from budget negotiations.
Options issued are designated as either an incentive stock or a non-statutory stock option. No option may be granted with a term of more than 10 years from the date of grant. Option awards may depend on achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares.
Options issued are designated as either an incentive stock or a non-statutory stock option. No option may be granted with a term of more than P10Y from the date of grant. Option awards may depend on the achievement of certain performance measures determined by the Compensation Committee of our Board. Shares issued upon option exercise are newly issued common shares.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 22 Forward Looking and Cautionary Statements You should read the following discussion in conjunction with the consolidated financial statements and the notes to those statements included elsewhere in this Annual Report on Form 10-K for the year ended September 30, 2022.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Forward Looking and Cautionary Statements You should read the following discussion in conjunction with the consolidated financial statements and the notes to those statements included elsewhere in this Annual Report on Form 10-K for the year ended September 30, 2023.
The Company continues to review its long-lived assets for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. Equipment and improvements are stated at cost.
The Company continues to review its long-lived assets for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. Equipment and improvements are stated at cost, less accumulated depreciation and amortization.
The VA is continuing to expand this program because of its ability to leverage VA providers and provide better services to veterans. Department of Health and Human Services The FY 2023 budget request proposes $127.3 billion in discretionary budget authority for HHS and $1.7 trillion in mandatory funding for the department.
The VA is continuing to expand this program because of its ability to leverage VA providers and provide better services to veterans. Department of Health and Human Services The FY 2024 budget request proposes $144.3 billion in discretionary budget authority for HHS and $1.7 trillion in mandatory funding for the department.
Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms. Intangible assets are originally recorded at fair value and amortized on a straight-line basis over their assessed useful lives. The assessed useful lives of the assets are 10 years.
Our right-of-use assets include long-term leases for facilities and equipment and are amortized over their respective lease terms. 33 Intangible assets are originally recorded at fair value and amortized on a straight-line basis over their assessed useful lives. The assessed useful lives of the assets are P10Y.
Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (3 to 7 years) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Costs incurred to place the asset in service are capitalized and costs incurred after implementation are expensed.
Depreciation and amortization are provided using the straight-line method over the estimated useful asset lives (P3Y to P7Y) and the shorter of the initial lease term or estimated useful life for leasehold improvements. Costs incurred to place the asset in service are capitalized and costs incurred after implementation are expensed.
This credit facility provides us with access of up to $25.0 million, subject to certain conditions including eligible accounts receivable. As of September 30, 2022, we had unused borrowing capacity of $23.0 million. The Company's present operating liabilities are largely predictable and consist of vendor and payroll related obligations.
This credit facility provides us with access of up to $70.0 million, subject to certain conditions including eligible accounts receivable. As of September 30, 2023, we had unused borrowing capacity of $32.0 million. The Company's present operating liabilities are largely predictable and consist of vendor and payroll related obligations.
Significant estimates include valuation of goodwill and intangible assets, stock-based compensation, and measurement of loss development on workers' compensation claims. In addition, the Company estimates overhead charges and allocates such charges throughout the year. Actual results could differ from those estimates. 30 Revenue Recognition We recognize revenue over time when there is a continuous transfer of control to our customer.
Significant estimates include valuation of goodwill and intangible assets, and stock-based compensation. In addition, the Company estimates overhead charges and allocates such charges throughout the year. Actual results could differ from those estimates. Revenue Recognition We recognize revenue over time when there is a continuous transfer of control to our customer.
This includes $12.2 billion for the Office of Head Start, principally to expand eligibility for participation in the program. Department of Defense The Military Health System ("MHS") is one of the largest health care systems, serving over 9 million beneficiaries.
This includes $13.1 billion for the Office of Head Start, principally to expand eligibility for participation in the program. 25 Department of Defense The Military Health System ("MHS") is one of the largest health care systems, serving over 9.5 million beneficiaries.
Goodwill The Company continues to review its goodwill for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. At September 30, 2022, we performed an internal goodwill impairment evaluation.
Goodwill The Company continues to review its goodwill for possible impairment or loss of value at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value.
The budget also requests $45 million for telehealth, which is $9 million above FY 2022 enacted, to promote health services with telehealth technologies. The budget also provides for investment in programs that improve the health and well-being of young children and their families.
The budget also requests $45.0 million for telehealth, which is an increase of $7.0 million above FY 2023 enacted, to promote health services with telehealth technologies. The budget also provides for investment in programs that improve the health and well-being of young children and their families.
Our primary focus within the defense agency markets include military service members' and veterans' requirements for telehealth services, behavioral healthcare, medication therapy management, process management, clinical systems support, and healthcare delivery. Our primary focus within the civilian agency markets includes healthcare and social programs delivery and readiness.
Our primary focus within the defense agency markets includes cyber security, military service members' and veterans' requirements for telehealth services, behavioral healthcare, medication therapy management, process management, clinical systems support, and healthcare delivery. Our primary focus within the civilian agency markets includes digital transformation, IT modernization, healthcare and social programs delivery and readiness.
The Company accessed funds from the secured revolving line of credit during the year, but has no outstanding balance at September 30, 2022. The secured term loan and secured revolving line of credit are secured by liens on substantially all of the assets of the Company.
The Company accessed funds from the secured revolving line of credit during the year, but had $9.5 million outstanding balance at September 30, 2023. The secured term loan and secured revolving line of credit are secured by liens on substantially all of the assets of the Company.
Specifically, the investment in public health infrastructure involves improving the nation’s readiness for future pandemics and other biological threats, expanding access to vaccines and healthcare, and defeating diseases and epidemics such as, but not limited to, the opioid and HIV/AIDs epidemics.
Specifically, the investment in public health infrastructure involves improving the nation’s readiness for future pandemics and other biological threats, expanding access to vaccines and healthcare, and defeating diseases and epidemics such as, but not limited to, the opioid and HIV/AIDS epidemics. The budget's initiatives are further reflected in the budget requests for the HHS, VA, and DoD.
The budget proposes $63 billion in discretionary and mandatory resources for NIH, an increase of $16 billion above FY 2022 enacted, to address the opioid crisis and ending HIV crises, make new investments in pandemic preparedness and nutrition research, and drive biomedical innovations.
The budget proposes $48.6 million in discretionary and mandatory resources for NIH, an increase of $920.0 million above FY 2023 enacted, to address the opioid crisis and ending HIV crises, make new investments in pandemic preparedness and nutrition research, and drive biomedical innovations.
If the appropriations bills are not timely enacted, government agencies operate under a continuing resolution ("CR"), which may negatively impact our business due to delays in new program starts, delays in contract award decisions, and other factors. On September 30, 2022, the President signed a CR providing funds to the federal government through December 16, 2022.
If the appropriations bills are not timely enacted, government agencies operate under a continuing resolution ("CR"), which may negatively impact our business due to delays in new program starts, delays in contract award decisions, and other factors.
The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Our actual results could differ materially from the results contemplated by these forward-looking statements.
The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Our actual results could differ materially from the results contemplated by these forward-looking statements. Business Overview: DLH is a holding company operating through a number of operating subsidiaries.
We performed a qualitative assessment of factors to determine whether it was necessary to perform the goodwill impairment test. Based on the results of the work performed, the Company has concluded that no impairment loss was warranted at September 30, 2022, as no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.
Based on the results of the work performed, the Company has concluded that no impairment loss was warranted at September 30, 2023, as no change in business conditions occurred which would have a material adverse effect on the valuation of goodwill.
The 2023 budget request for the VA's research enterprise is $916 million, an increase of $34 million from the 2022 budget, excluding mandatory funding. In addition, the 2023 budget estimates $4.8 billion will be spent on telehealth treatment in 2023, an increase of $622 million from the 2022 current estimate.
The FY 2024 budget request for the VA's research enterprise is $938.0 million, an increase of $22.0 million from the FY 2023 budget, excluding mandatory funding. In addition, the FY 2024 budget estimates $4.9 billion will be spent on telehealth treatment in FY 2024, an increase of $78.0 million from the FY 2023 estimate.
A summary of the change in cash is presented below for the years ended September 30, 2022 and 2021 (in thousands): 2022 2021 Net cash provided by operating activities $ 1,243 $ 45,665 Net cash used in investing activities (872) (44) Net cash used in by financing activities (24,194) (22,927) Net change in cash $ (23,823) $ 22,694 Sources of Cash As of September 30, 2022, our immediate sources of liquidity include cash of approximately $0.2 million, accounts receivable, and access to our secured revolving line of credit.
We expect to continue to use the operating cash flow to pay outstanding debt. 31 A summary of the change in cash is presented below for the years ended September 30, 2023 and 2022 (in thousands): 2023 2022 Net cash provided by operating activities $ 31,033 $ 1,243 Net cash used in investing activities (181,197) (872) Net cash provided by (used in) financing activities 150,151 (24,194) Net change in cash $ (13) $ (23,823) Sources of Cash As of September 30, 2023, our immediate sources of liquidity include cash of approximately $0.2 million, accounts receivable, and access to our secured revolving line of credit.
To restrict competition pursuant to this rule, the contracting officer must reasonably expect that at least two of these businesses, which are capable of delivering the services, will submit offers and that the award can be made at a fair and reasonable price that offers best value to the United States.
To restrict competition pursuant to this rule, the contracting officer must reasonably expect that at least two of these businesses, which are capable of delivering the services, will submit offers and that the award can be made at a fair and reasonable price that offers best value to the U.S, When two qualifying small businesses cannot be identified, the VA may proceed to award contracts following a full and open bid process.
The increase in revenue is due primarily to the two task orders awarded under a FEMA contract to support Alaska with its response to COVID-19. The revenue contribution from those task orders was $125.8 million.
The decrease in revenue is due primarily to the completion of two task orders awarded under a FEMA contract to support Alaska with its response to COVID-19. The revenue contribution from those task orders in fiscal year 2022 was $125.8 million. Included in fiscal 2023 revenue is $107.0 million contributed from GRSi subsequent to the acquisition.
These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs.
Cost of Operations Contract costs primarily include the costs associated with providing services to our customers. These costs are generally comprised of direct labor and associated fringe benefit costs, subcontract cost, other direct costs, and the related management and infrastructure costs.
We used less than $0.9 million and $0.1 million of cash in investing activities during fiscal years 2022 and 2021, respectively. The cash utilized was predominantly due to capital expenditures in fiscal year 2022 and 2021. Cash used in financing activities during the fiscal years ended September 30, 2022 and 2021 was approximately $24.2 million and $22.9 million, respectively.
The cash utilized was predominantly due to the acquisition of GRSi and capital expenditures in fiscal years 2023 and 2022, respectively. Cash used provided by financing activities during the fiscal year ended September 30, 2023 was approximately $150.2 million and cash used in financing activities during the fiscal year ended September 30, 2022 was $24.2 million, respectively.
Revenue for our firm-fixed-price contracts is recognized over time using a straight-line measure of progress or using the percentage-of-completion method whereby progress toward completion is based on a comparison of actual costs incurred to total estimated costs to be incurred over the contract term. Contract costs are expensed as incurred. Estimated losses are recognized when identified.
Revenue for our firm-fixed-price contracts is recognized over time using a straight-line measure of progress. Contract costs are expensed as incurred. Estimated losses are recognized when identified.
Department of Veterans Affairs The VA is requesting a total of $301.4 billion for FY 2023, an increase of $30.7 billion above the FY 2022 request. It includes $139.1 billion in discretionary funding, an increase of $21.9 billion, and $161.3 billion in mandatory funding, an increase of $8.6 billion from FY 2022 enacted.
Department of Veterans Affairs The VA is requesting a total of $325.1 billion for FY 2024, an increase of $16.6 billion above the FY 2023 enacted level. It includes $142.8 billion in discretionary funding, an increase of $3.0 billion, and $182.3 billion in mandatory funding, an increase of $13.6 billion from FY 2023 enacted.
It is anticipated that COVID-19 costs will decrease in FY 2023, driving a reduction in the budget request for DHP In Direct Care and Private Sector Care. 25 Industry consolidation among federal government contractors: There has been active consolidation and a strong increase in merger and acquisition activity among federal government contractors over the past few years that we expect to continue, fueled by public companies leveraging strong balance sheets.
Industry consolidation among federal government contractors: There has been active consolidation and a strong increase in merger and acquisition activity among federal government contractors over the past few years that we expect to continue, fueled by public companies leveraging strong balance sheets.
For additional information on risk factors that could impact our results, please refer to “Risk Factors” in Part I, Item 1A of this Form 10-K. 24 Federal budget outlook for fiscal year 2023: The President’s budget proposal for fiscal year ("FY") 2023 outlines many initiatives that include investments to rebuild our country’s physical infrastructure, strengthen supply chains, combat inflation, expand economic opportunity, respond to the changing climate, sustain and strengthen national defense, and bolster America's public health infrastructure.
Federal budget outlook for fiscal year 2024 : The President’s budget proposal for fiscal year ("FY") 2024 outlines many initiatives that include investments to rebuild our country’s physical infrastructure, strengthen supply chains, combat inflation, expand economic opportunity, respond to the changing climate, sustain and strengthen national defense, and bolster America's public health infrastructure.
The interest rate spread ranges from 2.5% to 4.5% depending on the funded indebtedness to adjusted EBITDA ratio. (a) Represents the principal amounts payable on our secured term loan, which is secured by liens on substantially all of the assets of the Company.
The remaining outstanding balance of our secured term loan is subject to interest rate fluctuations. (a) Represents the principal amounts payable on our secured term loan, which is secured by liens on substantially all of the assets of the Company.
For the year ended September 30, 2022, depreciation and amortization costs were approximately $1.1 million and $6.6 million, respectively, as compared to approximately $1.5 million and $6.6 million for the prior fiscal year, an aggregate decrease of $0.5 million. Interest Expense Interest expense includes items such as, interest expense and amortization of deferred financing costs on debt obligations.
Interest Expense Interest expense includes items such as interest expense and amortization of deferred financing costs on debt obligations. For the year ended September 30, 2023, interest expense was $16.3 million compared to interest expense, net of $2.2 million in the prior year, an increase of approximately $14.1 million over the prior year period.
Contractual Obligations as of September 30, 2022 Payments Due By Period Next 12 2-3 4-5 More than 5 (Amounts in thousands) Total Months Years Years Years Debt obligations $ 22,000 $ — $ 22,000 $ — $ — Facility operating leases 23,407 3,216 6,099 5,579 8,513 Equipment operating lease 135 83 52 — — Total contractual obligations $ 45,542 $ 3,299 $ 28,151 $ 5,579 $ 8,513 Critical Accounting Policies and Estimates Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
The provisions of the secured term loan and secured revolving line of credit, including financial covenants, are fully described in Note 8 to the consolidated financial statements. 32 Contractual Obligations as of September 30, 2023 Payments Due By Period Next 12 2-3 4-5 More than 5 (Amounts in thousands) Total Months Years Years Years Debt obligations $ 179,359 $ 8,313 $ 38,000 $ 133,046 $ — Facility operating leases 23,489 3,501 7,962 5,668 6,358 Equipment operating lease 50 50 — — — Contractual obligations $ 202,898 $ 11,864 $ 45,962 $ 138,714 $ 6,358 Critical Accounting Policies and Estimates Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the U.S.requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Notwithstanding this evaluation, factors including non-renewal of a major contract or other substantial changes in business conditions could have a material adverse effect on the valuation of goodwill in future periods and the resulting charge could be material to future periods’ results of operations. 31 Provision for Income Taxes The Company accounts for income taxes in accordance with the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.
Provision for Income Taxes The Company accounts for income taxes in accordance with the liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.
The principal of the secured term loan is payable in quarterly installments with the remaining balance due on September 30, 2025. On September 30, 2019, we executed a floating-to-fixed interest rate swap, with First National Bank ("FNB") as counter party.
On September 30, 2019, we executed a floating-to-fixed interest rate swap with First National Bank ("FNB") as counter party. The notional amount in the floating-to-fixed interest rate swap on September 30, 2023 is $16.2 million and matures in 2024 and the fixed rate of 1.61%.
However, the effect of set-aside provisions may limit our ability to compete for prime contractor positions on programs that we recompete or that we have targeted for growth. In these cases, the Company may elect to join a team with an eligible contractor as prime for specific pursuits that align with our core markets and corporate growth strategy.
The Company believes that its past performance in this market and track record of success provide a competitive advantage. However, the effect of set-aside provisions may limit our ability to compete for prime contractor positions on programs that we recompete or that we have targeted for growth.
General and administrative costs are for those employees not directly providing services to our customers, including but not limited to executive management, bid and proposal, accounting, and human resources.
General and administrative costs are for employees and third parties not directly providing services to our customers, including but not limited to executive management, bid and proposal, accounting, and human resources. These costs increased as compared to the prior fiscal year by $7.1 million to approximately $37.8 million primarily due to the acquisition of GRSi.
We believe that our current investment and financing obligations are adequately covered by cash generated from profitable operations and that planned operating cash flow should be sufficient to support our operations for twelve months from the date of issuance of these consolidated financial statements. 29 Credit Facilities A summary of our credit facilities as of September 30, 2022 is as follows (in millions): Lender Arrangement Loan Balance Interest * Maturity Date First National Bank of Pennsylvania Secured term loan (a) $ 22.0 LIBOR* + 2.5% 09/30/25 First National Bank of Pennsylvania Secured revolving line of credit (b) $ — LIBOR* + 2.5% 09/30/25 *LIBOR rate as of September 30, 2022 was 2.52%.
We believe that our current investment and financing obligations are adequately covered by cash generated from profitable operations and that planned operating cash flow should be sufficient to support our operations for twelve months from the date of issuance of these consolidated financial statements.
Definitions of these additional non-GAAP measures are set forth in the footnotes to the reconciliation table below. These non-GAAP measures of our performance are used by management to conduct and evaluate its business during its regular review of operating results for the periods presented.
These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance.
Results of Operations Fiscal Year Ended September 30, 2022 as Compared to Fiscal Year Ended September 30, 2021 The following table summarizes, for the years indicated, consolidated statements of operations data expressed (in thousands except for per share amounts, and as percentages of revenue): Year Ended September 30, 2022 2021 Change Revenue $ 395,173 100.0 % $ 246,094 100.0 % $ 149,079 Cost of operations Contract costs 322,886 81.7 % 194,614 79.1 % 128,272 General and administrative costs 30,730 7.8 % 25,054 10.2 % 5,676 Corporate development costs 614 0.2 % 1,088 0.4 % (474) Depreciation and amortization 7,665 1.9 % 8,115 3.3 % (450) Total operating costs 361,895 91.6 % 228,871 93.0 % 133,024 Income from operations 33,278 8.4 % 17,223 7.0 % 16,055 Interest expense 2,215 0.6 % 3,784 1.6 % (1,569) Income before provision for income taxes 31,063 7.8 % 13,439 5.4 % 17,624 Provision for income taxes 7,775 2.0 % 3,294 1.3 % 4,481 Net income $ 23,288 5.8 % $ 10,145 4.1 % $ 13,143 Net income per share - basic $ 1.82 $ 0.81 $ 1.01 Net income per share - diluted $ 1.64 $ 0.75 $ 0.89 Revenue For the year ended September 30, 2022 revenue was $395.2 million, an increase of $149.1 million or 60.6% over the prior year period.
In these cases, the Company may elect to join a team with an eligible contractor as prime for specific pursuits that align with our core markets and corporate growth strategy. 26 Results of Operations Fiscal Year Ended September 30, 2023 as Compared to Fiscal Year Ended September 30, 2022 The following table summarizes, for the years indicated, consolidated statements of operations data expressed (in thousands except for per share amounts, and as percentages of revenue): Year Ended September 30, 2023 2022 Change Revenue $ 375,872 100.0 % $ 395,173 100.0 % $ (19,301) Cost of operations Contract costs 296,016 78.8 % 322,886 81.8 % (26,870) General and administrative costs 37,795 10.1 % 30,730 7.8 % 7,065 Impairment loss of long-lived asset 7,673 2.0 % — — % 7,673 Corporate development costs 1,735 0.5 % 614 0.1 % 1,121 Depreciation and amortization 15,562 4.1 % 7,665 1.9 % 7,897 Total operating costs 358,781 95.5 % 361,895 91.6 % (3,114) Income from operations 17,091 4.5 % 33,278 8.4 % (16,187) Interest expense 16,271 4.3 % 2,215 0.6 % 14,056 Income before provision for income tax (benefit) expense 820 0.2 % 31,063 7.8 % (30,243) Provision for income tax (benefit) expense (641) (0.2) % 7,775 2.0 % (8,416) Net income $ 1,461 0.4 % $ 23,288 5.8 % $ (21,827) Net income per share - basic $ 0.11 $ 1.82 $ (1.71) Net income per share - diluted $ 0.10 $ 1.64 $ (1.54) Revenue For the year ended September 30, 2023 revenue was $375.9 million, a decrease of $19.3 million or 4.9% over the prior year period.
Cash flows from operations totaled approximately $1.2 million and $45.7 million for the years ended September 30, 2022 and 2021, respectively. The decrease in cash from operations was principally a result of performance of the deferred contract obligations on the FEMA task orders, for which an advance payment was received at the end of fiscal 2021.
Cash flows from operations totaled approximately $31.0 million and $1.2 million for the years ended September 30, 2023 and 2022, respectively. The increase in cash from operations was principally a result of a decrease in accounts receivable. We used $181.2 million and $0.9 million of cash in investing activities during fiscal years 2023 and 2022, respectively.
Management and our Board utilize these non-GAAP measures to make decisions about the use of our resources, analyze performance between periods, develop internal projections and measure 27 management's performance. We believe that these non-GAAP measures are useful to investors in evaluating our ongoing operating and financial results and understanding how such results compare with our historical performance.
We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance. These supplemental performance measurements may vary from and may not be comparable to similarly titled measures by other companies in our industry.
The activity in each fiscal year was primarily early repayment of principal on our secured term loan. During the year ended September 30, 2022 and 2021, the Company repaid approximately $24.8 million and $23.3 million of secured term loan principal, respectively. We expect to continue to use operating cash flow to pay outstanding debt.
The cash provided by financial activities during the fiscal year ended September 30, 2023, was primarily due to the debt incurred to finance the acquisition of GRSi during the fiscal year. The activity in the fiscal year ended September 30, 2022 was primarily due to the early repayment of principal on our secured term loan.
EBITDA for the remaining contract portfolio is calculated by subtracting the EBITDA attributable to the FEMA task orders from the Company’s total EBITDA. Liquidity and Capital Management For the year ended September 30, 2022, the Company generated operating income of approximately $33.3 million and net income of approximately $23.3 million.
(g) Tax effect is the impact the tax expense per the tax provision Liquidity and Capital Management The Company generated operating income of approximately $17.1 million and $33.3 million for the years ended September 30, 2023 and 2022, respectively and net income of approximately $1.5 million and $23.3 million for the years ended September 30, 2023 and 2022 respectively.
The notional amount in the floating-to-fixed interest rate swap as of September 30, 2022 is $16.2 million and matures in 2024. The remaining outstanding balance of our secured term loan is subject to interest rate fluctuations. (b) The secured revolving line of credit has a ceiling of up to $25.0 million and a maturity date of September 30, 2025.
The principal of the secured term loan is payable in quarterly installments with the remaining balance due on December 8, 2027. (b) The secured revolving line of credit has a ceiling of up to $70.0 million and a maturity date of December 8, 2027.
The FY 2023 UMB request for the Defense Health Program ("DHP") is $36.9 billion, a decrease of $0.4 billion from FY 2022 enacted.
The FY 2024 UMB request for the Defense Health Program ("DHP") is $58.7 billion, an increase of 0.5% from FY 2023 enacted. It is anticipated that COVID-19 costs will decrease in FY 2024, driving a reduction in the budget request for DHP In Direct Care and Private Sector Care.
We derive 99% of our revenue from agencies of the Federal government, providing services to several agencies including the Department of Veterans Affairs, Department of Health and Human Services, Department of Defense, and Department of Homeland Security.
We deliver improved health and cyber readiness solutions for federal government customers through digital transformation, science research and development, and systems engineering and integration. We derive 99% of our revenue from agencies of the Federal government, providing services to several agencies including the HHS, VA, DoD, and DHS.
For the year ended September 30, 2022, interest expense was $2.2 million compared to interest expense, net of $3.8 million in the prior year, a decrease of approximately $1.6 million over the prior year period. The decrease in interest expense was primarily due to the decreased balance on our secured term loan.
The increase in interest expense was primarily due to the increase in long-term debt associated with the acquisition of GRSi during the fiscal year. Provision for Income Taxes Provision for Income taxes for the fiscal year ended September 30, 2023 was a reduction of tax by $0.6 million, a decrease of approximately $8.4 million from the prior fiscal year.
Provision for Income Taxes Provision for Income taxes for the fiscal year ended September 30, 2022 was $7.8 million, an increase of approximately $4.5 million from the prior fiscal year. The effective tax rate was 24.8% and 24.5% for the fiscal years ending September 30, 2022 and 2021 respectively.
The effective tax rate was a negative 72.2% for the fiscal year ending September 30, 2023 and 24.8% for the fiscal year ending September 30, 2022. Non-GAAP Financial Measures for Fiscal 2023 and 2022 The Company is presenting certain non-GAAP measures regarding its financial performance for the fiscal years ended September 30, 2023 and 2022.